Lupin Signs ADHD Drugs Deal With Aytu In Canada

Local Registration And Authorizations Expected Over The Next 18-To-24 Months

Lupin has added two ADHD drugs to its Canadian portfolio, while also signing multiple branded deals in other global markets.

Map of Canada and pills in the background — • Source: Shutterstock

Indian giant Lupin has signed an exclusive deal with Aytu BioPharma, adding two drugs for the treatment of attention deficit hyperactivity disorder to its Canadian portfolio.

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Generics Bulletin for daily insights

Start your 7-day free trial
Explore trusted news, analysis, and insights
Access comprehensive global coverage
Enjoy instant access – no credit card required

Start Free Trial

Already a subscriber?

Lupin Signs ADHD Drugs Deal With Aytu In Canada

Local Registration And Authorizations Expected Over The Next 18-To-24 Months

Read the full article – start your free trial today!

More from Deals

More from Business